Europe Plant-based Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, and Others), Source (Tobacco Plant, Maize, Potato, and Others), and Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, and Others)

No. of Pages: 132    |    Report Code: TIPRE00026267    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Plant-based Vaccines Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Plant-based Vaccines Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Plant-based Vaccines Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing number of research and development activities in plant-based vaccines
5.2 Market Opportunities
  • 5.2.1 Advancement in Production of Plant-Based Vaccines Create Lucrative Growth Opportunities
5.3 Future Trends
  • 5.3.1 Growing prevalence of infectious disease creates demand for plant based Vaccines
5.4 Impact of Drivers and Restraints

6. Europe Plant-based Vaccines Market Regional Analysis

6.1 Europe Plant-based Vaccines Market Overview
6.2 Europe Plant-based Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Europe Plant-based Vaccines Market Forecast Analysis

7. Europe Plant-based Vaccines Market Analysis – by Vaccine Type

7.1 Bacterial Vaccines
  • 7.1.1 Overview
  • 7.1.2 Bacterial Vaccines: Europe Plant-based Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Viral Vaccines
  • 7.2.1 Overview
  • 7.2.2 Viral Vaccines: Europe Plant-based Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Parasite Vaccines
  • 7.3.1 Overview
  • 7.3.2 Parasite Vaccines: Europe Plant-based Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Plant-based Vaccines Market Analysis – by Source

8.1 Tobacco Plant
  • 8.1.1 Overview
  • 8.1.2 Tobacco Plant: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Maize
  • 8.2.1 Overview
  • 8.2.2 Maize: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Potato
  • 8.3.1 Overview
  • 8.3.2 Potato: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Plant-based Vaccines Market Analysis – by Application

9.1 Influenza
  • 9.1.1 Overview
  • 9.1.2 Potato: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Zika Virus
  • 9.2.1 Overview
  • 9.2.2 Potato: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Ebola Virus
  • 9.3.1 Overview
  • 9.3.2 Potato: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Poultry Disease
  • 9.4.1 Overview
  • 9.4.2 Potato: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Plant-based Vaccines Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Plant-based Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Plant-based Vaccines Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
    • 10.1.1.1.2 UK: Europe Plant-based Vaccines Market Breakdown, by Source
    • 10.1.1.1.3 UK: Europe Plant-based Vaccines Market Breakdown, by Application
  • 10.1.1.2 Germany: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
    • 10.1.1.2.2 Germany: Europe Plant-based Vaccines Market Breakdown, by Source
    • 10.1.1.2.3 Germany: Europe Plant-based Vaccines Market Breakdown, by Application
  • 10.1.1.3 France: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
    • 10.1.1.3.2 France: Europe Plant-based Vaccines Market Breakdown, by Source
    • 10.1.1.3.3 France: Europe Plant-based Vaccines Market Breakdown, by Application
  • 10.1.1.4 Russia: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
    • 10.1.1.4.2 Russia: Europe Plant-based Vaccines Market Breakdown, by Source
    • 10.1.1.4.3 Russia: Europe Plant-based Vaccines Market Breakdown, by Application
  • 10.1.1.5 Italy: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
    • 10.1.1.5.2 Italy: Europe Plant-based Vaccines Market Breakdown, by Source
    • 10.1.1.5.3 Italy: Europe Plant-based Vaccines Market Breakdown, by Application
  • 10.1.1.6 Rest of Europe: Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
    • 10.1.1.6.2 Rest of Europe: Europe Plant-based Vaccines Market Breakdown, by Source
    • 10.1.1.6.3 Rest of Europe: Europe Plant-based Vaccines Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Plant-based Vaccines Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 British American Tobacco p.l.c.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Creative Biolabs, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Leaf Expression Systems Ltd.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 LenioBio
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Lumen Bioscience, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 ZYUS Life Sciences Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. British American Tobacco p.l.c.
  2. Creative Biolabs, Inc.     
  3. Leaf Expression Systems Ltd.
  4. LenioBio
  5. Lumen Bioscience, Inc.
  6. ZYUS Life Sciences Inc.
europe-plant-based-vaccines-market